Advertisement

Medical Therapy of Reflux Esophagitis

  • G. N. J. Tytgat

Abstract

Elevation of the head of the bed is objectively proved to be an effective therapeutic measure to decrease nocturnal reflux, superior to propping the patient’s head and shoulders on extra pillows. Avoidance of recumbency after meals, of straining to lift heavy objects, of tight garments, etc. is also advisable.

Keywords

Lower Esophageal Sphincter Reflux Esophagitis Evening Meal Prokinetic Drug Comparative Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tytgat GN (1981) Assessment of the efficacy of Cimetidine and other drugs in oesophageal reflux disease. In: Baron JH (ed) Cimetidine in the 80’s. Edingburgh, pp 153–166Google Scholar
  2. 2.
    Saco LS, Orlanso RC, Levinson SL, Bozynski EM, Jones JD, Frakes JT (1982) Double-blind controlled trial of bethanechol and antacid versus placebo and antacid in the treatment of erosive esophagitis. Gastroenterology 82:1369PubMedGoogle Scholar
  3. 3.
    Thanik K, Chey WY, Shak A, Hamilton D, Nadelson N (1982) Bethanechol or Cimetidine in the treatment of symptomatic reflux esophagitis. Arch Intern Med 142:1479–1481PubMedCrossRefGoogle Scholar
  4. 4.
    Masci E, Testoni PA, Passaretti S, Guslandi M, Tittobello A (1985) Comparison of ranitidine, domperidone maleate and ranitidine + domperidone maleate in the short-term treatment of reflux oesophagitis. Drugs Exp Clin Res 11:687–692PubMedGoogle Scholar
  5. 5.
    Guslandi M, Testoni PA, Passaretti S et al. (1983) Ranitidine vs metoclopramide in the medical treatment of reflux oesophagitis. Hepatogastroenterol 30(3):96Google Scholar
  6. 6.
    Martin-Abreu L (1987) Cisapride in chronic symptomatic reflux oesophagitis: a double-blind placebo-controlled study. (to be published)Google Scholar
  7. 7.
    Janisch HD, Bouzo MH, Hüttemann W, Kleinert J, Pfeiffer H, Eisenhardt W, Von Radetzky E (1987) Double-blind comparison of Cisapride with Ranitidine in the treatment of reflux oesophagitis. (to be published)Google Scholar
  8. 8.
    Galmiche JO, Brandstatter G, Kerstan E, Reichel W, Schutze K, Vitaux J, Vogten AJM (1987) Double-blind placebo-controlled study of Cisapride as add-on therapy in patients treated with Cimetidine for reflux oesophagitis. (to be published)Google Scholar
  9. 9.
    Weiss W, Brunner H, Büttner G, Gabor M, Miederer S, Mittelstaedt A, Olbermann M, Schwamberger K, Wizel L (1983) Therapie der Refluxösophagitis mit Sucralfat. Dtsch Med Wochenschr 108:1706–1711PubMedCrossRefGoogle Scholar
  10. 10.
    Laitinen S, Stahlberg M, Kairaluoma MI, Kimnicmi H, Pääkönen M, Lahtinen J, Poikolainen E, Aukee S (1985) Sucralfate and alginate/antacid in reflux esophagitis. Scand J Gastroenterol 20:229–232PubMedCrossRefGoogle Scholar
  11. 11.
    Hameeteman W, v. d. Boomgaard DM, Dekker W, Schrijver M, Wesdorp ICE, Tytgat GNJ (1987) Sucralfate versus Cimetidine in reflux esophagitis, a single blind multicentre study. J Clin Gastroenterol (to be published)Google Scholar
  12. 12.
    Simon B, Beckenbach HP, Kühn V, Lang H, Spohr V, Daake H, Schink V (1987) Wirksamkeitsvergleich von Sucralfat and Ranitidin bei der Refluxoesophagitis. (to be published)Google Scholar
  13. 13.
    Chevrel B (1980) A comparative crossover study on the treatment of heartburn and epigastric pain: liquid gaviscon and a magnesium — aluminium antacid gel. J Int Med Res 8:300PubMedGoogle Scholar
  14. 14.
    Furman D, Marsh R, Winan G, Marignani P, McKinley M, Dubovik S, McCallum RW (1982) A double-blind trial comparing high dose liquid antacid to placebo and Cimetidine in improving symptoms and objective parameters of gastroesophageal reflux. Gastroenterology 82:1062Google Scholar
  15. 15.
    Graham DY, Patterson DJ (1983) Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis. Dig Dis Sci 28:559–563PubMedCrossRefGoogle Scholar
  16. 16.
    Grove O, Bekker C, Jeppe Hansen MG, Karstoft E, Sanchez G, Axelsson CK, Nielsen HO, Andersen B, Rask-Madsen J (1985) Ranitidine and high-dose antacid in reflux oesophagitis. Scand J Gastroenterol 20:457–461PubMedCrossRefGoogle Scholar
  17. 17.
    Breen KJ, Desmond PV, Whelan G (1983) Treatment of reflux oesophagitis. A randomized, controlled evaluation of Cimetidine. Med J Aust 2:555–556PubMedGoogle Scholar
  18. 18.
    Berstad A (1982) Overview of ranitidine in reflux oesophagitis: its effect on symptoms, endoscopic appearance and histology. In: Misiewicz, Wormsley (eds) The clinical use of ranitidine, 2nd ranitidine-symposium, London, Oct 1981. Med Publ Found, pp 297–304Google Scholar
  19. 19.
    Sherbaniuk R, Wensel A (1982) Trautmann A. Ranitidine in the short-term managements of symptomatic gastro-oesophageal reflux. In: Misiewicz, Wormsley (eds) The clinical use of ranitidine, 2nd ranitidine symposium, London, Oct 1981. Med Public Found, pp 283 – 290Google Scholar
  20. 20.
    Wesdorp ICE, Dekker W, Klinkenberg-Knol EC (1983) The treatment of reflux oesophagitis with ranitidine. Gut 24:921PubMedCrossRefGoogle Scholar
  21. 21.
    Goy JAEJ, Maynard W (1983) McNaughton: ranitidine in reflux oesophagitis — a double-blind controlled trial. Abstracts from Gastroenterological Society of Australia, scientific meeting, Oct 11–12Google Scholar
  22. 22.
    Elizalde RO, Manauta JP, Sanjurjo JL, Tovar AV, Deffesus Villalobos Peres J (1983) Ranitidine treatment of reflux esophagitis and duodenal and gastric ulcer. Invest Med Int 10:3–6Google Scholar
  23. 23.
    Hine HR, Holmes GKT, Melikian V, Lucey M, Fairclough PD (1984) Ranitidine in reflux oesophagitis. A double-blind placebo-controlled study. Digestion 29:119–123PubMedCrossRefGoogle Scholar
  24. 24.
    McCallum RW, Eshelman F, Nardi R (1984) Double-blind multicenter trial to compare the efficacy of ranitidine and placebo in the short-term treatment of chronic gastro esophageal reflux disease. Gastroenterology 86:1179Google Scholar
  25. 25.
    Bhakri HL, Cocking JB, Farley MD (1982) A comparative study of ranitidine and Cimetidine in the treatment of reflux oesophagitis. Glaxo, data on fileGoogle Scholar
  26. 26.
    Noya G, Dettori G, Muscas A, Spirito R, Niolu P, Marongiu G, Biglioli P (1983) Cimetidina versus ranitidina nel trattamento dell’esofagite peptica. Min Med 74:787–790Google Scholar
  27. 27.
    Fielding JF, Doyle GD (1984) Comparison between ranitidine and Cimetidine in the treatment of reflux esophagitis. Irish Med J 77:356–357Google Scholar
  28. 28.
    Kimmig JM (1984) Cimetidine and ranitidine in the treatment of reflux esophagitis. Z Gastroenterol 22:373–378PubMedGoogle Scholar
  29. 29.
    Anonymous (1987) Cimetidine and metoclopramide in the treatment of reflux esophagitis. A multi-centre study. Smith Kline and French, PhiladelphiaGoogle Scholar
  30. 30.
    Temple JG, Bradby GVH, O’Connor F, Panesar KS, Mulligan TO, Robinson TJ, Ward DW (1983) Cimetidine and metoclopramide in oesophageal reflux disease. Br Med J 286:1863–1864CrossRefGoogle Scholar
  31. 31.
    Lieberman DA, Keeffe EB (1986) Treatment of severe reflux esophagitis with Cimetidine and metoclopramide. Ann Intern Med 104:21–26PubMedGoogle Scholar
  32. 32.
    Kaul B, Petersen, Erichsen H, Myrvold HE, Grette K, Halvosen, Fjosne U (1986) Gastroesophageal reflux disease: acute and maintenance treatments with Cimetidine. Scand J Gastroenterol 21:139–145PubMedCrossRefGoogle Scholar
  33. 33.
    Bright-Asare P, Behar J, Brand DL (1982) Effects of long-term maintenance Cimetidine therapy on gastroesophageal reflux disease. Gastroenterology 82:1025Google Scholar
  34. 34.
    Koelz HR, Bircher R, Bron R (1982) Behandlung der Refluxösophagitis mit Ranitidin. Eine multizentrische prospektive Studie. Schweiz Med Wochenschr 112:1901PubMedGoogle Scholar
  35. 35.
    Ottenjann R, Siewert JR, Heilman K, Neiss A, Döpfer H (1987) Treatment of reflux-oesophagitis. results of a multicenter study. In: Siewert JR, Hölscher AH (eds) Diseases of the Esophagus. Springer Berlin Heidelberg New York Tokyo, p 1125Google Scholar
  36. 36.
    Hetzel DJ, Dent J, Laurence BH, Reed WD, Narielvaja F, Shearman DJC (1986) Omeprazole heals reflux oesophagitis: a placebo controlled trial. British Society of Gastroenterology, Lancaster (abstract)Google Scholar
  37. 37.
    Dammann HG, Blum AL, Lux G, Rehner M, Riecken EO, Schiessel R, Wienbeck M, Witzel L, Berger J (1986) Unterschiedliche Heilungstendenz der Refluxösophagitis nach Omeprazol und Ranitidin. Dtsch Med Wochenschr 111:123–128PubMedCrossRefGoogle Scholar
  38. 38.
    Dawson J, Barnard J, Delattre M (1987) Cimetidine 800 mg at bedtime in reflux oesophagitis: a multicenter trial. In: Siewert JR, Hölscher AH (eds) Diseases of the Esophagus. Springer Berlin Heidelberg New York Tokyo, p 1118Google Scholar
  39. 39.
    Thor K (1986) Treatment of reflux esophagitis with Cimetidine in a liquid suspension. Curr Ther Res 39:2–8Google Scholar
  40. 40.
    Richter JE (1986) Treatment of severe reflux esophagitis. Ann Intern Med 104:588–589PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • G. N. J. Tytgat
    • 1
  1. 1.Division of GastroenterologyAcademic Medical CentreAmsterdamThe Netherlands

Personalised recommendations